Prostate Cancer Proliferation Is Affected by the Subcellular Localization of MCT2 and Accompanied by Significant Peroxisomal Alterations.
MCT2
peroxisomes
prostate cancer
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
27 Oct 2020
27 Oct 2020
Historique:
received:
18
09
2020
revised:
20
10
2020
accepted:
21
10
2020
entrez:
30
10
2020
pubmed:
31
10
2020
medline:
31
10
2020
Statut:
epublish
Résumé
Reprogramming of lipid metabolism directly contributes to malignant transformation and progression. The increased uptake of circulating lipids, the transfer of fatty acids from stromal adipocytes to cancer cells, the
Identifiants
pubmed: 33121137
pii: cancers12113152
doi: 10.3390/cancers12113152
pmc: PMC7693163
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Fundação para a Ciência e Tecnologia
ID : PTDC/BIA-CEL/31378/2017
Références
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cancer Res. 2010 Oct 15;70(20):8117-26
pubmed: 20876798
Prostate. 2005 Jun 1;63(4):316-23
pubmed: 15599942
Oncogenesis. 2016 Jan 25;5:e189
pubmed: 26807644
J Biol Chem. 2017 Jan 13;292(2):691-705
pubmed: 27899449
Int J Mol Sci. 2016 Jul 02;17(7):
pubmed: 27384557
Nat Rev Cancer. 2007 Oct;7(10):763-77
pubmed: 17882277
J Microsc. 2006 Dec;224(Pt 3):213-32
pubmed: 17210054
J Inherit Metab Dis. 1995;18 Suppl 1:113-24
pubmed: 9053546
J Pathol. 2015 Aug;236(4):517-30
pubmed: 25875424
FEBS J. 2008 Mar;275(6):1089-102
pubmed: 18279392
Biochem Biophys Res Commun. 2003 Apr 25;304(1):130-5
pubmed: 12705896
J Cell Physiol. 2016 Dec;231(12):2664-72
pubmed: 26945682
Biochem Biophys Res Commun. 2003 Mar 21;302(4):898-903
pubmed: 12646257
Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):2880-4
pubmed: 9096315
J Bioenerg Biomembr. 2008 Jun;40(3):123-6
pubmed: 18780167
J Cell Biol. 1989 Apr;108(4):1353-61
pubmed: 2925789
Prostate Cancer Prostatic Dis. 2006;9(3):230-4
pubmed: 16683009
Biochim Biophys Acta. 2014 Apr 4;1841(4):563-8
pubmed: 24333844
J Biol Chem. 1994 Aug 19;269(33):21277-83
pubmed: 8063752
Front Physiol. 2017 Feb 21;8:97
pubmed: 28270771
Oncogene. 2006 Aug 7;25(34):4777-86
pubmed: 16892090
FASEB J. 2019 Mar;33(3):4355-4364
pubmed: 30540494
J Cell Biol. 2017 Feb;216(2):331-342
pubmed: 28108524
J Med Genet. 2017 May;54(5):330-337
pubmed: 27799409
J Lipid Res. 2007 Aug;48(8):1846-56
pubmed: 17496269
J Cell Mol Med. 2015 Apr;19(4):723-33
pubmed: 25639644
Mol Cancer Ther. 2011 Mar;10(3):427-36
pubmed: 21282354
Prostate. 2013 May;73(7):763-9
pubmed: 23192371
J Biol Chem. 1997 Oct 10;272(41):26023-31
pubmed: 9325339
Oncotarget. 2017 Jun 13;8(24):38264-38275
pubmed: 28415728
Nat Rev Cancer. 2013 Apr;13(4):227-32
pubmed: 23446547
J Lipid Res. 2010 Oct;51(10):2863-95
pubmed: 20558530
Anticancer Res. 2010 Feb;30(2):369-74
pubmed: 20332441
Am J Pathol. 2004 Mar;164(3):787-93
pubmed: 14982833
Int J Mol Sci. 2019 May 28;20(11):
pubmed: 31142021
J Proteome Res. 2015 Aug 7;14(8):3390-402
pubmed: 26147661
Biochim Biophys Acta Bioenerg. 2017 Aug;1858(8):665-673
pubmed: 28283400
Cancer Res. 2002 Apr 15;62(8):2220-6
pubmed: 11956072
Biochim Biophys Acta. 2016 Oct;1863(10):2481-97
pubmed: 26993058
Biochim Biophys Acta. 2011 Mar;1811(3):148-52
pubmed: 21145416
Science. 1956 Feb 24;123(3191):309-14
pubmed: 13298683
Methods Mol Biol. 2013;931:467-82
pubmed: 23027018